Your browser doesn't support javascript.
loading
Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells.
Reimondez-Troitiño, Sonia; González-Aramundiz, José V; Ruiz-Bañobre, Juan; López-López, Rafael; Alonso, María J; Csaba, Noemi; de la Fuente, María.
Afiliación
  • Reimondez-Troitiño S; Nano-Oncology Unit, Translational Medical Oncology Group, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital of Santiago de Compostela (CHUS), CIBERONC, Santiago de Compostela, Spain; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Depart
  • González-Aramundiz JV; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, Santiago de Compostela, Spain; Departamento de Farmacia, Facultad de Química y de Farmacia, Pontificia
  • Ruiz-Bañobre J; Nano-Oncology Unit, Translational Medical Oncology Group, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital of Santiago de Compostela (CHUS), CIBERONC, Santiago de Compostela, Spain.
  • López-López R; Nano-Oncology Unit, Translational Medical Oncology Group, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital of Santiago de Compostela (CHUS), CIBERONC, Santiago de Compostela, Spain.
  • Alonso MJ; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, Santiago de Compostela, Spain.
  • Csaba N; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, Santiago de Compostela, Spain. Electronic address: noemi.csaba@usc.es.
  • de la Fuente M; Nano-Oncology Unit, Translational Medical Oncology Group, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital of Santiago de Compostela (CHUS), CIBERONC, Santiago de Compostela, Spain. Electronic address: maria.de.la.fuente.freire@sergas.es.
Eur J Pharm Biopharm ; 142: 449-459, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31326581
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protaminas / Neoplasias Colorrectales / MicroARNs / Proliferación Celular / Nanocápsulas Límite: Humans Idioma: En Revista: Eur J Pharm Biopharm Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protaminas / Neoplasias Colorrectales / MicroARNs / Proliferación Celular / Nanocápsulas Límite: Humans Idioma: En Revista: Eur J Pharm Biopharm Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos